Hemispherx BioPharma (HEB) Stock: Climbing On Clinical Update

Hemespherx BioPharma HEB Stock News

Hemispherx BioPharma, Inc (NYSEAMERICAN: HEB) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced significant progress in a clinical oncology program. Read my full report on HEB here! As you could imagine, the news excited investors, pushing the stock on a run for the top. … Read more

Moleculin Biotech (MBRX) Stock: Up Big On Clinical Update

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced a clinical update, exciting investors and sending the stock up. Today, we’ll talk about: The update; what we’re seeing from MBRX stock as a result; and what we’ll be watching for … Read more

Innovate Biopharmaceuticals (INNT) Stock: Climbing On Data

Innovate Biopharmaceuticals INNT Stock News

Innovate Biopharmaceuticals Inc (NASDAQ: INNT) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive data, exciting investors and sending the stock for the top. Today, we’ll talk about: The data that was released; what we’re seeing from INNT stock as a result; and what … Read more

Pluristem Therapeutics (PSTI) Stock: Gaining On Clinical Update

Pluristen Therapeutics PSTI Stock News

Pluristem Therapeutics Inc. (NASDAQ: PSTI) is having an incredibly strong start to the trading session this morning, and for good reason. The company provided a clinical update, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The clinical update; what we’re seeing from PSTI stock as a result; … Read more

Moleculin Biotech (MBRX) Stock: Gaining On Leukemia Drug Program Expansion

Moleculin Biotech MBRX Stock News

Moleculin Biotech Inc (NASDAQ: MBRX) is having a great day in the market today, and for good reason. The company announced the successful expansion of a clinical drug program. As you could imagine, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The successful drug … Read more

Tonix Pharmaceuticals (TNXP) Stock: Gaining On Expanded Phase 3 Program

Tonix Pharmaceuticals TNXP Stock News

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) is making a run for the top in the market this morning, and for good reason. The comapny announced that it would be expanding a late-stage clinical development program. As you could imagine, the news excited investors, sending the stock on a run for the top. Today, we’ll talk … Read more

Biogen (BIIB) Stock: Tumbling On Scrapped Phase 3 Development Program!

Biogen BIIB Stock News

Biogen Inc (NASDAQ: BIIB) is falling hard in the pre-market hours this morning, and for good reason. The company announced that it would be putting an end to a Phase 3 development program, upsetting investors and sending the stock tumbling down. Today, we’ll talk about: The scrapped development program; what we’re seeing from BIIB stock … Read more

Ampio Pharmaceuticals (AMPE) Stock: Climbing On Clinical Update

Ampio Pharmaceuticals Inc (NYSEAMERICAN: AMPE) is having a strong start to the trading session this morning, and for good reason. The company announced a clinical update, exciting investors who are pushing the stock on a run for the top. Today, we’ll talk about: The update; what we’re seeing from AMPE stock as a result; and … Read more